Fifth Third Bancorp Buys 39,726 Shares of The Clorox Company $CLX

Fifth Third Bancorp grew its position in shares of The Clorox Company (NYSE:CLX) by 830.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,507 shares of the company’s stock after acquiring an additional 39,726 shares during the quarter. Fifth Third Bancorp’s holdings in Clorox were worth $4,612,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wilkins Investment Counsel Inc. lifted its holdings in Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares during the period. Morningstar Investment Management LLC grew its stake in Clorox by 131.8% in the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock valued at $6,297,000 after purchasing an additional 35,506 shares during the period. National Pension Service grew its stake in Clorox by 68.9% in the 4th quarter. National Pension Service now owns 27,537 shares of the company’s stock valued at $2,777,000 after purchasing an additional 11,233 shares during the period. Swiss Life Asset Management Ltd increased its position in shares of Clorox by 221.4% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after purchasing an additional 59,533 shares during the last quarter. Finally, Birch Hill Investment Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at $22,103,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by insiders.

Clorox Trading Down 2.6%

Shares of Clorox stock opened at $96.13 on Friday. The stock has a market capitalization of $11.62 billion, a P/E ratio of 15.61, a P/E/G ratio of 0.47 and a beta of 0.54. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock’s 50-day simple moving average is $94.59 and its 200 day simple moving average is $104.01.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts anticipate that The Clorox Company will post 5.52 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CLX. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. BNP Paribas Exane lowered their price objective on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. Evercore reiterated an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. Citigroup decreased their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, Royal Bank Of Canada lowered their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $103.47.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.